| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.62 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |